Allogeneic double-negative T cell therapy for relapsed acute myeloid leukemia patients post allogeneic hematopoietic stem cell transplantation: A first-in-human phase I study.
Baolin TangJong Bok LeeSiqi ChengTianzhong PanWen YaoDongyao WangMeijuan TuZhiqiang XiangXiandeng ChuLiangquan GengPing QiangPingping TengGuangyu SunHuilan LiuJian WangAaron D SchimmerLiming YangZimin SunLi ZhangXiaoyu ZhuPublished in: American journal of hematology (2022)
Keyphrases
- acute myeloid leukemia
- allogeneic hematopoietic stem cell transplantation
- acute lymphoblastic leukemia
- end stage renal disease
- ejection fraction
- endothelial cells
- newly diagnosed
- chronic kidney disease
- stem cell transplantation
- prognostic factors
- multiple myeloma
- diffuse large b cell lymphoma
- low dose
- induced pluripotent stem cells